Q16558 (KCMB1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 107.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Calcium-activated potassium channel subunit beta-1 Alternative name(s): BK channel subunit beta-1 Short name=BKbeta Short name=BKbeta1 Short name=Hbeta1 Calcium-activated potassium channel, subfamily M subunit beta-1 Short name=Calcium-activated potassium channel subunit beta Charybdotoxin receptor subunit beta-1 K(VCA)beta-1 Maxi K channel subunit beta-1 Slo-beta-1 Short name=Slo-beta | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 191 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Regulatory subunit of the calcium activated potassium KCNMA1 (maxiK) channel. Modulates the calcium sensitivity and gating kinetics of KCNMA1, thereby contributing to KCNMA1 channel diversity. Increases the apparent Ca2+/voltage sensitivity of the KCNMA1 channel. It also modifies KCNMA1 channel kinetics and alters its pharmacological properties. It slows down the activation and the deactivation kinetics of the channel. Acts as a negative regulator of smooth muscle contraction by enhancing the calcium sensitivity to KCNMA1. Its presence is also a requirement for internal binding of the KCNMA1 channel opener dehydrosoyasaponin I (DHS-1) triterpene glycoside and for external binding of the agonist hormone 17-beta-estradiol (E2). Increases the binding activity of charybdotoxin (CTX) toxin to KCNMA1 peptide blocker by increasing the CTX association rate and decreasing the dissociation rate. |
| Subunit structure | Interacts with KCNMA1 tetramer. There are probably 4 molecules of KCMNB1 per KCNMA1 tetramer. |
| Subcellular location | |
| Tissue specificity | Abundantly expressed in smooth muscle. Low levels of expression in most other tissues. Within the brain, relatively high levels found in hippocampus and corpus callosum. |
| Post-translational modification | N-glycosylated. Ref.11 |
| Polymorphism | Genetic variation in KCNMB1 can influence the severity of diastolic hypertension. |
| Sequence similarities | Belongs to the KCNMB (TC 8.A.14.1) family. KCNMB1 subfamily. [View classification] |
Ontologies
| Keywords | |
|---|---|
| Biological process | Ion transport Transport |
| Cellular component | Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Transmembrane Transmembrane helix |
| Molecular function | Ion channel |
| PTM | Glycoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | blood coagulation Traceable author statement. Source: Reactome response to calcium ionInferred from electronic annotation. Source: Compara synaptic transmissionTraceable author statement. Source: Reactome |
| Cellular_component | plasma membrane Traceable author statement. Source: Reactome voltage-gated potassium channel complexInferred from electronic annotation. Source: Compara |
| Molecular_function | calcium-activated potassium channel activity Traceable author statement Ref.1. Source: ProtInc potassium channel regulator activityTraceable author statement Ref.1. Source: ProtInc |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q16558-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q16558-2) The sequence of this isoform differs from the canonical sequence as follows: 103-130: CSYIPGSVDNYQTARADVEKVRAKFQEQ → VLNWRDGDTSLYPCQVCEPVPNCPCPRG 131-191: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed By similarity | ||||||
| Chain | 2 – 191 | 190 | Calcium-activated potassium channel subunit beta-1 | PRO_0000187046 | |||||
Regions | |||||||||
| Topological domain | 2 – 18 | 17 | Cytoplasmic Potential | ||||||
| Transmembrane | 19 – 39 | 21 | Helical; Name=1; Potential | ||||||
| Topological domain | 40 – 157 | 118 | Extracellular Potential | ||||||
| Transmembrane | 158 – 178 | 21 | Helical; Name=2; Potential | ||||||
| Topological domain | 179 – 191 | 13 | Cytoplasmic Potential | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 80 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 142 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Alternative sequence | 103 – 130 | 28 | CSYIP…KFQEQ → VLNWRDGDTSLYPCQVCEPV PNCPCPRG in isoform 2. | VSP_009822 | |||||
| Alternative sequence | 131 – 191 | 61 | Missing in isoform 2. | VSP_009823 | |||||
| Natural variant | 65 | 1 | E → K Has a protective effect against diastolic hypertension. Ref.14 Corresponds to variant rs11739136 [ dbSNP | Ensembl ]. | VAR_019325 | |||||
| Natural variant | 110 | 1 | V → L. Corresponds to variant rs2301149 [ dbSNP | Ensembl ]. | VAR_047009 | |||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A calcium switch for the functional coupling between alpha (hslo) and beta subunits (KV,Ca beta) of maxi K channels." Meera P., Wallner M., Jiang Z., Toro L. FEBS Lett. 382:84-88(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Uterus. |
| [2] | "Phenotypic alteration of a human BK (hSlo) channel by hSlobeta subunit coexpression: changes in blocker sensitivity, activation/relaxation and inactivation kinetics, and protein kinase A modulation." Dworetzky S.I., Boissard C.G., Lum-Ragan J.T., McKay M.C., Post-Munson D.J., Trojnacki J.T., Chang C.P., Gribkoff V.K. J. Neurosci. 16:4543-4550(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Uterus. |
| [3] | "Cloning, expression, and distribution of a Ca(2+)-activated K+ channel beta-subunit from human brain." Tseng-Crank J., Godinot N., Johansen T.E., Ahring P.K., Strobaek D., Mertz R., Foster C.D., Olesen S.P., Reinhart P.H. Proc. Natl. Acad. Sci. U.S.A. 93:9200-9205(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1). Tissue: Brain. |
| [4] | "Sequence of the gene encoding the beta subunit of a human, large-conductance, calcium-activate, K+ channel." Folander K., Biazzo D., Swanson R. Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1). Tissue: Aortic smooth muscle. |
| [5] | "Identification of potassium channels in human lens epithelium." Rae J.L., Shepard A.R. (In) Civan M.M. (eds.); The eye's aqueous humor, from secretion to glaucoma, pp.69-104, Academic Press, San Diego (1998) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [6] | "Calcium-activated potassium channel expression in human myometrium: effect of pregnancy." Mazzone J.N., Kaiser R.A., Buxton I.L.O. Proc. West. Pharmacol. Soc. 45:184-186(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Myometrium. |
| [7] | "Role of the BK-beta1 subunit in human mesangial cells." Pluznick J.L., Sansom S.C. Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [8] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Cervix. |
| [9] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [10] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Pancreas. |
| [11] | "A neuronal beta subunit (KCNMB4) makes the large conductance, voltage- and Ca2+-activated K+ channel resistant to charybdotoxin and iberiotoxin." Meera P., Wallner M., Toro L. Proc. Natl. Acad. Sci. U.S.A. 97:5562-5567(2000) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION. |
| [12] | "Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit." Valverde M.A., Rojas P., Amigo J., Cosmelli D., Orio P., Bahamonde M.I., Mann G.E., Vergara C., Latorre R. Science 285:1929-1931(1999) [PubMed] [Europe PMC] [Abstract] Cited for: BINDING TO E2. |
| [13] | "New disguises for an old channel: MaxiK channel beta-subunits." Orio P., Rojas P., Ferreira G., Latorre R. News Physiol. Sci. 17:156-161(2002) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [14] | "Gain-of-function mutation in the KCNMB1 potassium channel subunit is associated with low prevalence of diastolic hypertension." Fernandez-Fernandez J.M., Tomas M., Vazquez E., Orio P., Latorre R., Senti M., Marrugat J., Valverde M.A. J. Clin. Invest. 113:1032-1039(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT LYS-65. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | U25138 mRNA. Translation: AAB02394.1. U38907 mRNA. Translation: AAA81327.1. U42600 mRNA. Translation: AAB16827.1. U42601 Genomic DNA. Translation: AAB16825.1. U42603, U42602 Genomic DNA. Translation: AAB16826.1. U61536 mRNA. Translation: AAB61396.1. U61537 Genomic DNA. Translation: AAB61397.1. AF026002 mRNA. Translation: AAB88805.1. AY044441 mRNA. Translation: AAK95827.1. AY515264 mRNA. Translation: AAS20193.1. AK313979 mRNA. Translation: BAG36693.1. CH471062 Genomic DNA. Translation: EAW61474.1. BC025707 mRNA. Translation: AAH25707.1. |
| IPI | IPI00748067. IPI00828136. |
| PIR | S68842. |
| RefSeq | NP_004128.1. NM_004137.3. |
| UniGene | Hs.484099. |
3D structure databases | |
| ProteinModelPortal | Q16558. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q16558. 1 interaction. |
| MINT | MINT-1470084. |
| STRING | 9606.ENSP00000274629. |
Protein family/group databases | |
| TCDB | 8.A.14.1.2. Ca2+-activated K+ channel auxiliary subunit slowpoke-beta (Slobeta) family. |
PTM databases | |
| PhosphoSite | Q16558. |
Polymorphism databases | |
| DMDM | 292495100. |
Proteomic databases | |
| PRIDE | Q16558. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000274629; ENSP00000274629; ENSG00000145936. ENST00000521859; ENSP00000427940; ENSG00000145936. |
| GeneID | 3779. |
| KEGG | hsa:3779. |
| UCSC | uc003maq.1. human. uc003mar.3. human. |
Organism-specific databases | |
| CTD | 3779. |
| GeneCards | GC05M169737. |
| HGNC | HGNC:6285. KCNMB1. |
| HPA | HPA020435. |
| MIM | 603951. gene. 608622. phenotype. |
| neXtProt | NX_Q16558. |
| PharmGKB | PA221. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG40171. |
| HOVERGEN | HBG052223. |
| InParanoid | Q16558. |
| KO | K04937. |
| OMA | YQRLYGP. |
| OrthoDB | EOG47SSFT. |
| PhylomeDB | Q16558. |
Enzyme and pathway databases | |
| Reactome | REACT_13685. Neuronal System. REACT_604. Hemostasis. |
Gene expression databases | |
| Bgee | Q16558. |
| CleanEx | HS_KCNMB1. |
| Genevestigator | Q16558. |
| GermOnline | ENSG00000145936. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR003930. K_chnl_Ca-activ_BK_bsu. [Graphical view] |
| PANTHER | PTHR10258. PTHR10258. 1 hit. |
| Pfam | PF03185. CaKB. 1 hit. [Graphical view] |
| PRINTS | PR01450. BKCHANNELB. |
| ProtoNet | Search... |
Other | |
| BindingDB | Q16558. |
| ChEMBL | CHEMBL5078. |
| GenomeRNAi | 3779. |
| NextBio | 14829. |
| SOURCE | Search... |
Entry information
| Entry name | KCMB1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q16558 Secondary accession number(s): O00707 Q93005 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 5 Human chromosome 5: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
